Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.96 USD
Change Today -0.01 / -0.51%
Volume 787.6K
As of 12:28 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven B. Ketchum Ph.D.

Senior Vice President and President of Research & Development, Amarin Corporation plc
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
49$1,198,590
As of Fiscal Year 2014

Background*

Dr. Steven B. Ketchum, PhD has been a Senior Vice President and President of Research & Development at Amarin Corporation Plc Since February 16, 2012. Dr. Ketchum served as Senior Vice President of Research and Development at Sunesis Pharmaceuticals Inc. from June 2008 to February 2012. Dr. Ketchum has more than fifteen years experience in late-stage product development and clinical regulatory strategy, having led the filings of multiple successful New Drug Applications ...

Read Full Background

Corporate Headquarters*

2 Pembroke House
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 669 9020
Fax: --

Board Members Memberships*

2012-Present
Director

Education*

PhD
University College London
BS
Stanford University

Other Affiliations*

Annual Compensation*

Salary$404,750
Total Annual Compensation$404,750

Stock Options*

Restricted Stock Awards$345,780
Exercisable Options492,500
Unexercisable Options343,750
Total Number of Options836,250

Total Compensation*

Total Annual Cash Compensation$523,342
Total Short Term Compensation$404,750
Other Long Term Compensation$345,780
Total Calculated Compensation$1,198,590
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $1.96 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
$301.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$643.4K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.